These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34228405)

  • 1. ADHD Masquerading as Cautopyreiophagia Exacerbated by Risperidone and Improved With Methylphenidate in a Preschooler.
    Naguy A
    Prim Care Companion CNS Disord; 2021 Jul; 23(4):. PubMed ID: 34228405
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylphenidate an effective treatment for ADHD?
    McDougle CJ
    J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of metilpheniydate, risperidone and combination therapy on ECG in children with attention-deficit hyperactivity disorder.
    Karpuz D; Hallioglu O; Toros F; Tasdelen B
    J Electrocardiol; 2017; 50(4):410-415. PubMed ID: 28274540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed - Results from a randomized, double-blind, placebo-controlled clinical trial.
    Jahangard L; Akbarian S; Haghighi M; Ahmadpanah M; Keshavarzi A; Bajoghli H; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
    Psychiatry Res; 2017 May; 251():182-191. PubMed ID: 28213188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate-Induced Persistent Hiccups in a Child With ADHD Relieved by Add-On Risperidone.
    Alamiri B; Naguy A
    Am J Ther; 2020 Oct; 28(6):e706-e707. PubMed ID: 33021543
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents.
    Mohamoud M; Chen Q; Croteau D; Cheng C; Burkhart K; Volpe DA; Kortepeter C; Demczar D; Stone M
    J Clin Psychopharmacol; 2022 May-Jun 01; 42(3):238-246. PubMed ID: 35489029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone-to-methylphenidate switch reaction in children: three cases.
    Sabuncuoglu O
    J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antipsychotic agents and stimulants: a judicious combination?].
    de Jong MH; Eussen ML; van Gool AR
    Tijdschr Psychiatr; 2010; 52(1):57-61. PubMed ID: 20054798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder.
    Wigal S; Chappell P; Palumbo D; Lubaczewski S; Ramaker S; Abbas R
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):104-118. PubMed ID: 31967914
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
    Ekinci O; Sabuncuoglu O
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):648-9. PubMed ID: 21134409
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP; Thompson A
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Punding Under Methylphenidate Treatment in a Patient With Adult Attention-Deficit/Hyperactivity Disorder.
    Aydin Ö; Tanriöver E; Poyraz CA
    J Clin Psychopharmacol; 2020; 40(6):631-632. PubMed ID: 33136926
    [No Abstract]   [Full Text] [Related]  

  • 15. Tardive Oculogyric Crisis With Low-Dose Antipsychotic in an Adolescent: A Case Report.
    Gnanavel S
    Prim Care Companion CNS Disord; 2018 Nov; 20(6):. PubMed ID: 30476369
    [No Abstract]   [Full Text] [Related]  

  • 16. Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder.
    Biederman J; Spencer T
    J Atten Disord; 2002; 6 Suppl 1():S101-7. PubMed ID: 12685524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Zarinara AR; Mohammadi MR; Hazrati N; Tabrizi M; Rezazadeh SA; Rezaie F; Akhondzadeh S
    Hum Psychopharmacol; 2010 Nov; 25(7-8):530-5. PubMed ID: 20860068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate-Induced Enuresis: 3 Case Reports.
    Uzun N; Akinci MA; Karatoprak S
    Clin Neuropharmacol; 2021 Jan-Feb 01; 44(1):37-38. PubMed ID: 33252370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotempla XR-ODT--another long-acting methylphenidate for ADHD.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):183-185. PubMed ID: 29125594
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/ Hyperactivity Disorder.
    Greenhill L; Beyer DH; Finkleson J; Shaffer D; Biederman J; Conners CK; Gillberg C; Huss M; Jensen P; Kennedy JL; Klein R; Rapoport J; Sagvolden T; Spencer T; Swanson JM; Volkow N
    J Atten Disord; 2002; 6 Suppl 1():S89-100. PubMed ID: 12685523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.